1. Home
  2. LNTH vs CRDO Comparison

LNTH vs CRDO Comparison

Compare LNTH & CRDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lantheus Holdings Inc.

LNTH

Lantheus Holdings Inc.

HOLD

Current Price

$100.64

Market Cap

6.6B

Sector

Health Care

ML Signal

HOLD

Logo Credo Technology Group Holding Ltd

CRDO

Credo Technology Group Holding Ltd

HOLD

Current Price

$186.85

Market Cap

50.7B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
LNTH
CRDO
Founded
1956
2008
Country
United States
Cayman Islands
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
6.6B
50.7B
IPO Year
2014
2022

Fundamental Metrics

Financial Performance
Metric
LNTH
CRDO
Price
$100.64
$186.85
Analyst Decision
Buy
Strong Buy
Analyst Count
6
14
Target Price
$87.00
$179.62
AVG Volume (30 Days)
903.8K
7.2M
Earning Date
05-07-2026
06-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
765.52
EPS
2.91
0.67
Revenue
$343,374,000.00
$1,335,116,000.00
Revenue This Year
N/A
$210.92
Revenue Next Year
$14.19
$57.22
P/E Ratio
$34.57
$261.92
Revenue Growth
3.62
205.68
52 Week Low
$49.67
$86.49
52 Week High
$111.86
$308.67

Technical Indicators

Market Signals
Indicator
LNTH
CRDO
Relative Strength Index (RSI) 47.53 46.81
Support Level $100.51 $170.90
Resistance Level $101.43 $204.97
Average True Range (ATR) 0.45 9.59
MACD 0.09 1.37
Stochastic Oscillator 41.96 48.31

Price Performance

Historical Comparison
LNTH
CRDO

About LNTH Lantheus Holdings Inc.

Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.

About CRDO Credo Technology Group Holding Ltd

Credo Technology Group Holding Ltd provides connectivity solutions for AI-driven applications, cloud computing, and hyperscale networks. Its high-speed copper and optical interconnect products support data infrastructure demands. The Company's product portfolio includes ZeroFlap (ZF) Active Electrical Cables (AECs), ZF optical transceivers, OmniConnect memory solutions, and retimers and DSPs for optical and copper Ethernet and PCIe, leveraging the PILOT diagnostic and analytics software platform. Its products are based on Serializer/Deserializer (SerDes) and Digital Signal Processor (DSP) technologies and include integrated circuits (ICs), Active Electrical Cables (AECs), SerDes Chiplets, and SerDes IP licensing solutions. The United States generates the maximum revenue.

Share on Social Networks: